Advancing ADHD understanding, treatment, and advocacy across Australasia.
About AADPA
Advancing ADHD understanding, treatment, and advocacy across Australasia.
The Australasian ADHD Professionals Association (AADPA) is the leading independent, not-for-profit organisation connecting and empowering professionals dedicated to improving the lives of people with ADHD across Australia and New Zealand.
Our members include clinicians, researchers, educators, policy makers, and individuals with lived experience — all working together to create a future where people with ADHD and their families can thrive at every stage of life.
We are united by one purpose: to drive meaningful change that advances ADHD understanding, treatment, and advocacy across Australasia.
Education & Training
Conduct & support education of those working in the field of ADHD and share our knowledge on ADHD with the broader community.
ADHD Advocacy
Advocate for individuals with ADHD and their families for the purpose of more effective access to ADHD services and treatment.
Policy Development
Formalize best practices for the diagnosis and treatment of ADHD in Australia, identify key research and public policy priorities.
ADHD Research
Promote and facilitate evidence-based research into the diagnosis, causes and treatment of ADHD for enhanced lifetime outcomes.
Our Values
AADPA is founded on a vision shared by professional disciplines, consumers and other stakeholders.
We have
Credibility
We pride ourselves on our ability to collaborate across disciplines. We have demonstrated transparency and a successful track record for achieving our objectives.
Commitment
We are committed to delivering outcomes that will improve the lives of those living with ADHD and facilitate thriving, by ensuring the membership has a diversity of voices, knowledge, and lived experience that can inform our decision-making and priority-setting.
Authority
Our diverse membership includes national and international leaders in their respective disciplines, consumers and community stakeholders, as well as the next generation of clinicians and researchers.
Insight
We are committed to increasing the involvement of people with lived experience in all our activities.
We are
Independent
We place a high value on being an ‘honest broker’ which is made possible by our strong network relationships and our united purpose.
Effective
We have and will continue to provide an authoritative evidence-based voice that influences and develops policy initiatives that are consumer-focused, affordable, equitable, and importantly, deliverable.
Inclusive
We understand the needs and priorities of clinicians, researchers and the community and will expand AADPA member involvement in future initiatives. We are committed to including the often-overlooked voices of Indigenous and CALD communities in our policy development and on our Board.
Innovative
We seek opportunities that will empower professionals to provide best-practice ADHD assessment, treatment and supports and enable consumers to make their own decisions about how to best manage their ADHD symptoms.
Our Board Of Directors
AADPA’s Board brings together leaders in psychiatry, medicine, psychology, neuroscience, pharmacy, and lived experience advocacy. Together, they guide our strategy, shape our policy, and ensure that every decision is grounded in both scientific evidence and real-world impact.
Prof. David Coghill
President
Academic Child and Adolescent Psychiatrist at the University of Melbourne and Royal Children’s Hospital Melbourne, internationally recognised for ADHD research and clinical expertise.
Dr Sarahn Lovett
Vice President
Paediatrician with a special interest in neonatal intensive care, autism, and children with chronic and complex conditions.
Prof. Mark Bellgrove
Director
Director of the Turner Institute for Brain and Mental Health and a Professor in Cognitive Neuroscience in the School of Psychological Sciences at Monash University.
Dr Kyle Hoath
Director
Dr. Hoath is a psychiatrist specializing in adult ADHD diagnosis and management, with expertise in comorbidities and ADHD in elite athletes.
Katarzyna Tognarini
Appointed Director
Katarzyna (Kate), is a practising community pharmacist with over 25 years of experience working in community, education, industry and hospital.
Dr Will Errington
Casual Director
Dr Will Errington is a General Practitioner, Co-Chair of the RACGP Special Interest Group, and College educator and examiner.
Rebecca Alexander
Director
Rebecca Alexander is a Clinical Psychologist specializing in ADHD diagnosis and treatment across the lifespan.
Dr Chris Soo
Director
Dr. Chris Soo is a GP and physiotherapist with lived experience of AuDHD, who practices full-time ADHD management
Dr Sarah Watson
Director (New Zealand)
Auckland based Child & Adolescent Clinical Psychologist with over 20 years’ experience supporting children, adolescents, and families, specialising in ADHD, ASD, and OCD.
Nikki Searby
Company Secretary
A seasoned commercial lawyer with a wide breadth of exposure to different areas of law and a passion for advocacy and inclusivity, particularly within neurodiverse workplaces.
Annual Reports
Continuing to deliver on our commitment to working towards enhanced lifetime outcomes for individuals with ADHD and their families has led to many achievements for the Australian ADHD Professionals Association. The below reports contain a summary of our progress, statistics, research and more.
